Clinical Operations Overview
QPS Clinical Operations supports drug development in every clinical stage with a strong focus on Phase II-IV clinical trials and medical device studies. QPS Clinical Operations offices are located in the USA. Austria, Croatia, Czech Republic, Germany, India, Netherlands, Spain, and Taiwan. We conduct and manage clinical studies in accordance with International Conference on Harmonization-Good Clinical Practice (ICH-GCP) standards and all applicable regulatory requirements to pharmaceutical and scientific clients.
QPS Phase I-IV Clinical Services
Clinical Trials Kits
QPS has added a new capability, building clinical trial kits. We offer individualized service, fast turnaround times, and can ship to any global clinical trial site. Contact Us (link to contact form) for more information.
Data Management
Data management for successful clinical trials. Data management is a fundamental element of a successful trial. This step is critical to your success.
Medical Writing
High-quality medical writing is important to the regulatory success of our clients. Our medical writing writers have the therapeutic expertise necessary to deliver high-quality written material.
Pharmacovigilance
At QPS, we have systems in place to enable the identification, recording, reporting and analysis of safety information so that any safety signals that arise during a trial are quickly identified and acted upon.
Project Management and Site Monitoring
The QPS clinical trial monitoring and management teams are an integral part of the successful completion of any clinical research project. They ensure that trials are ethical and efficient and produce valid, reliable data.
Links to Relevant Documents
- Efficiently Performing Two Global Approval Studies in Prostate Cancer Patients
- Phase II-IV Clinical Overview
- Phase II-IV Clinical Services & Locations
- Early Phase Clinical Overview
- Expedited Study Delivery – Logistics
- Expedited Study Delivery – Pharmacy
- Studying Sedatives in Phase I Studies
- Pharmacokinetic Studies in Patients
- Corporate Overview Clinical Sites
Testimonials
Such a high-quality submission, followed by a similarly high-quality pre-clinical, non-clinical and CMC program, along with high-quality QC, organization, summaries and interpretation of dozens of reports; all accomplished just about a year after we nominated the clinical candidate.
Thank you for your contribution to the successful delivery of this historic company milestone.